Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients

A prospective, multicentre, phase IIIb study with an exploratory, open-label design was conducted to evaluate efficacy and safety of anidulafungin for the treatment of candidaemia/invasive candidiasis (C/IC) in specific ICU patient populations. Adult ICU patients with confirmed C/IC meeting ≥1 of th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ruhnke, M, Paiva, J A, Meersseman, W, Pachl, J, Grigoras, I, Sganga, G, Menichetti, F, Montravers, P, Auzinger, G, Dimopoulos, G, Borges Sá, M, Miller, P J, Marček, T, Kantecki, M
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2012
Matèries:
Mycology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3510306/
https://ncbi.nlm.nih.gov/pubmed/22404732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1469-0691.2012.03784.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars